Patient Representative Opportunities

Do you represent a 501(c)(3) organization that serves constituents with major chronic diseases and/or rare/orphan diseases? Then you can’t afford to miss this opportunity to attend the DIA 2014 50th Annual Meeting.

What is the DIA 2014 50th Annual Meeting?

DIA 2014 50th Annual Meeting connects all partners involved in bringing new therapies to patients. Historically, this enterprise has focused on drug development, but today those partners include a very diverse range of stakeholders from biotechnology, diagnostics, and medical device companies, to regulatory agencies, scientific and academic communities, service payers and providers, and patient organizations. See for Yourself...

“At the DIA Annual Meeting, I was given access to a wealth of enlightening educational sessions that offered distinctive new perspectives from industry and drug companies, and policy makers and regulators.  I was also exposed to fascinating information about research positioning, study designs and precision medicine.  As a result, I better understand bringing drugs to market, fast-tracking medications, funding and incentives for all parties, consortiums, protocols and improving patient outcomes.”

-Colleen Zak, ARPKD/CHF Alliance
“DIA facilitates education and meetings with credible patient advocates to engage and collaborate with the industry, policymakers, healthcare professionals, academia and others. The Patient Advocate Fellowship Program is a well-managed, effective, disciplined and fun program.”

-Jack Whelan, Author, Lecturer, Research Advocate, Cancer Warrior & Survivor

Special Discount for Patient Advocates!

Representatives of patient organizations can attend the Annual Meeting for $250. A one-year complimentary DIA e-membership is also included. Proof of 501(c)3 status required.

By attending the DIA Annual Meeting, you will have the opportunity to:

  • Develop, strengthen, and support patient collaborations and those of patients you represent with policy makers, health professionals, industry representatives, and academia
  • Increase your knowledge and understanding of patient groups about key issues central to patient-centered health care, biomedical research, and drug development, and take this wealth of information back to your constituency
  • Improve alliances between the patient groups you represent and other health care stakeholders
  • Stimulate cooperation, promote dialogue, and share best practices on both personal and organizational levels

Download a copy of the registration form or for questions about eligibility?
Contact Elizabeth Lincoln at